调节NLRP3与反意义寡核酸的拼接,以控制病理性炎症.
bioRxiv : the preprint server for biology
|September 16, 2024
概括
研究人员开发了拼接切换反感性寡核酸 (ASO) 以通过向NLRP3炎症酶来控制致病性炎症. 这种方法产生了非功能NLRP3蛋白质变体,在临床前模型中有效降低了炎症.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 炎症对于愈合至关重要,但如果未解决,会有害,造成危及生命的风险.
- 作为先天免疫系统的一部分,NLRP3炎症体感知细胞应激,是炎症性疾病的治疗点.
- 对NLRP3RNA的替代拼接可以产生非功能性蛋白质异型,这表明它在炎症酶激活中起着调节作用.
研究的目的:
- 设计能够调节NLRP3炎症酶活性的拼接切换反感性寡核酸 (ASO).
- 为了确定诱导非功能NLRP3拼接异型的ASO,从而控制致病性炎症.
- 评估ASO在减少NLRP3信号和全身炎症方面的有效性.
主要方法:
- 选针对NLRP3RNA的不同表因子的反感性寡核化物 (ASO).
- 在实验室中评估ASO对NLRP3剪接,蛋白质水平和炎症酶活性的影响.
- 在小鼠模型中测试最有效的ASO急性炎症和冷素相关周期性综合征 (CAPS) in vivo.
主要成果:
- 鉴定出几种ASO在体外成功调节了NLRP3剪接并减少了炎症体信号传递.
- ASO显著降低了NLRP3蛋白水平和炎症酶激活.
- 最有效的ASO在活体小鼠模型中证明了抑制系统性炎症的有效性.
结论:
- 拼接切换ASO代表了蛋白质工程控制蛋白质功能的可行策略.
- 这种方法可以产生具有治疗意义的NLRP3异型,其炎症活性降低.
- 一种已识别的ASO通过降低功能NLRP3.3的调节有效地治疗小鼠的病理性炎症.
相关概念视频
Inflammatory Response
1.9K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
1.9K
RNA Splicing
56.2K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.2K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K


